Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
glp-1 cgm Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research firmness Variety:Quarterly Subscription uhc glp 1 coverage
uhc glp 1 coverage United Health Care briefing and their "concerns" re GLP1 trends/data : r/ glp1 Employers Take a Variety of –
Medical Necessity Checklist for Formulary Exception If you're requesting a formulary exception, gather this documentation first: Required Documentation for Exception Request Current BMI documentation (≥30 or ≥27 with comorbidity) Documented comorbidities with ICD-10 codes: Obesity Class I/II/III (E66.811, E66.812, E66.813) Hypertension (I10) Type 2 Diabetes (E11) Dyslipidemia (E78.5) Obstructive Sleep Apnea (G47.33) Failed alternative treatments — documented trials of: Phentermine or diethylpropion Qsymia or Contrave Semaglutide (Wegovy/Ozempic) for 6+ months Lifestyle modification records (diet/exercise program participation) Weight history showing chronic obesity (past 1-2 years) Letter of Medical Necessity from your Kaiser provider For more on prior auth documentation, see our Zepbound prior auth checklist → EXCEPTION PATHWAYS How Some Members Get Coverage While standard coverage is limited, some Kaiser members do get Zepbound covered
firmness
Variety:Quarterly Subscription
Many trials did not report sex differences or long-term outcomes for women specifically
US$ 21.02
US$ 24.54
US$ 26.38
US$ 22.56
US$ 20.78
US$ 28.79
US$ 22.39
US$ 28.56
US$ 20.91
